Acute Crit Care.  2020 Aug;35(3):226-227. 10.4266/acc.2020.00241.

Suggestions and tips regarding polymyxin B-immobilized fiber column direct hemoperfusion of neonates with sepsis

• Nishizaki N

• KMID: 2506106
• DOI: http://doi.org/10.4266/acc.2020.00241

Reference

1. Kim YA, Kim H, Kim YM, Park SE. A successful application of adult polymyxin B-immobilized fiber column hemoperfusion to a neonate with septic shock. Acute Crit Care. 2019; 34:284–8.

2. Nishizaki N, Hara T, Obinata K, Nakagawa M, Shimizu T. Clinical Effects and outcomes after polymyxin B-immobilized fiber column direct hemoperfusion treatment for septic shock in preterm neonates. Pediatr Crit Care Med. 2020; 21:156–63.

3. Nishizaki N, Nakagawa M, Hara S, Oda H, Kantake M, Obinata K, et al. Effect of PMX-DHP for sepsis due to ESBL-producing E. coli in an extremely low-birthweight infant. Pediatr Int. 2016; 58:411–4.

4. Nishizaki N, Hirano D, Miyasho T, Obinata K, Shoji H, Shimizu T. Evaluation of urinary IL-6 in neonates with septic shock treated with polymyxin B-immobilized fiber column. Pediatr Int. 2017; 59:1032–3.